Shulou(Shulou.com)12/24 Report--

Thanks to CTOnews.com netizen Feitian Noodle Cult chief leader for the clue delivery! CTOnews.com News on November 23, CTOnews.com learned from the official public account of CNNC that recently, with the support of CNNC's Longteng Innovation Project, CNNC's China Institute of Atomic Energy's "BNCT intense proton cyclotron prototype development" project successfully passed technical acceptance, marking the successful development of the first boron neutron capture therapy (BNCT) prototype based on intense cyclotron in China. It provides a solid guarantee for the next step of BNCT commodity machine finalization and clinical technology research, and strongly promotes the achievement transformation of BNCT equipment in the next step.

Boron neutron capture therapy (BNCT) is an emerging binary, targeted, cellular approach to tumor therapy. Its principle of action is to inject boron medicine into the human body. This boron medicine is like a 'engineer' sent out to actively bury 'mines' around cancer cells. Under the neutron irradiation generated by BNCT equipment, these 'mines' can trigger a 'nuclear explosion' with only 1-2 cell scales to destroy cancer cells, with minimal damage to other normal tissues and cells.

Experts from Institute of Modern Physics of Chinese Academy of Sciences, Tsinghua University, Wuhan University, Huazhong University of Science and Technology, Sichuan University, North China Electric Power University and Institute of Aerospace 23, as well as leaders and project team members of Institute of Nuclear Technology and Institute of Reactor Engineering Technology of Atomic Energy Academy attended the technical acceptance meeting. The expert group listened to the technical summary report of the project team, checked the test results, and issued acceptance opinions after questions and inquiries. All experts unanimously stated that the prototype test results met the design index requirements, completed all the research contents specified in the task book, and some technical indexes were better than the requirements of the task book. The expert group suggested grasping the opportunity, increasing investment and speeding up the research on clinical key technologies.

BNCT is one of the most advanced cancer targeted therapy technologies in the field of international cancer therapy in recent years. It can be used in the treatment of head and neck tumors, melanoma and other cancers. The project team of "BNCT intense proton cyclotron prototype development" composed of Institute of Nuclear Technology and Institute of Reactor Engineering Technology of Atomic Energy Institute successfully broke through intense cyclotron technology, neutron target and moderator technology, and realized mA magnitude current strong extraction capability of small cyclotron. In the next step, the clinical key technology research work based on this device will be carried out as soon as possible, so as to realize the transformation of achievements as soon as possible and make contributions to the medical and health cause of our country.

Welcome to subscribe "Shulou Technology Information " to get latest news, interesting things and hot topics in the IT industry, and controls the hottest and latest Internet news, technology news and IT industry trends.